Nordion Inc (NYSE:NDZ)

11.30
Data as of Apr 15
 -0.07 / -0.62%
Today’s Change
6.70
Today|||52-Week Range
11.62
+33.10%
Year-to-Date
SECTOR
Health Services
INDUSTRY
Services to the Health Industry
MARKET CAP
$702.7M

Company Description

Nordion, Inc. is a global health science company that provides market-leading products and services such as medical isotopes, targeted therapies and sterilization technologies used for the prevention, diagnosis and treatment of disease. Its products and services are used by pharmaceutical and biotechnology companies, medical-device manufacturers, hospitals, clinics and research laboratories. The company operates through three segments: Targeted Therapies, Sterilization Technologies and Medical Isotopes. The Targeted Therapies segment focuses on the treatment of various cancers through TheraSphere, which is used in the treatment of inoperable primary and metastatic liver cancer and metastatic liver cancer. The Sterilization Technologies segment focused on the prevention of disease through terminal sterilization of medical products and devices which includes surgeon's gloves, syringes, sutures and catheters, as well as food and consumer products. This segment engaged in design, construction, produce and installation of Cobalt-60, a radiation sources isotope that produces the gamma radiation that destroys harmful microorganisms, which is used in medical products including, disposable medical devices and supplies such as surgeon's gloves, syringes, sutures and catheters, as well as pharmaceuticals. Gamma sterilization is also used for the treatment of food and consumer products. The Medical Isotopes segment focused on the diagnosis and treatment of diseases, including cardiac and neurological conditions and several types of cancer. Nordion was founded in 1946 and is headquartered in Mississauga, Canada.

Contact Information

Nordion, Inc.
447 March Road
Ottawa Ontario K2K 1X8
P:(613) 591-6917
Investor Relations:
190559234001022

Employees

Shareholders

Other institutional66.61%
Mutual fund holders20.42%
Individual stakeholders--

Top Executives

Steven M. WestPresident, CEO, COO & Director
G. Peter DansChief Financial Officer
Grant GardinerSecretary, Senior Vice President & General Counsel
Scott McIntoshChief Operating Officer-Specialty Isotopes
Tom BurnettGeneral Manager-Medical Isotopes

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.